AIM ImmunoTech Inc. · AMEX:AIM

Equels Thomas K bought 31,675 AIM ImmunoTech Inc. shares (Form 4)

Traded Oct 23, 2026 · Filed Oct 26, 2026

On Oct 23, 2026, Equels Thomas K (Director, CEO & President) bought 31,675 AIM ImmunoTech Inc. shares at US$0.16 for US$5,068, leaving 189,747 shares. Filed Oct 26, 2026 (Form 4).

Bought
31,675 shares
Price
US$0.16
Value
US$5,068
Holding after
189,747 shares
Trading plan
No
Role
Director, CEO & President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 23, 2026Common StockBuy31,675US$0.16189,747Direct

Source

Download original · View original at SEC

Related